Epigentek Home

Product Categories

UBE2E3 Monoclonal Antibody [4C4]


Base Product #: A-8113              Availability: Usually Ships In 1-2 Days
Share:
Displaying 1 to 1 (of 1 products) Result Pages:  1 
 Catalog No.+   Product Name   Select Qty.   Price 
 A-8113-100  UBE2E3 Monoclonal Antibody [4C4] (100 µg)   $388.00 
Product Overview

Description
Mouse monoclonal antibody raised against a partial recombinant UBE2E3, clone 4C4.

Size
100 µg

Purification
Protein A purified

Immunogen
UBE2E3 (NP_006348, 65 a.a. ~ 153 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.

Cross Reactivity
Human

Isotype
IgG2a Kappa

Formulation
In 1x PBS, pH 7.2

Storage
Aliquot and store at -20ºC or lower. Avoid repeated freezing and thawing. Multiple freeze/thaw cycles may result in decreased performance.

Handling Recommendations
For maximum recovery of the products, centrifuge the vial prior to opening the cap.

Applications & Suggested Dilutions*
ELISA: 0.25-1 µg/ml

*The end user is responsible for determining optimal working dilutions.

 

Note: This item was formerly catalog no. ABB-8014 (ABB8014)

Product Details

Applications

Western Blot

Not determined

Immunoprecipitation Not determined

ELISA


Detection limit for recombinant GST tagged UBE2E3 is approximately 1 ng/ml as a capture antibody.

Immunohistochemistry (IHC)

Not determined

Immunofluorescence

Not determined
User Guide & MSDS

[User Guide]*
*Always use the actual User Guide that shipped with your product. Is the above file locked? You can also request user guides by emailing info@epigentek.com along with your contact information and institution name.

Feedback Form
Epigentek is an epigenetics company that specializes in epigenetic kits, antibodies, reagents, and services for epigenetic research in DNA methylation, histone modification, and chromatin studies.

Copyright © 2012 Epigentek Group Inc. All rights reserved.
Epigentek, the Epigentek logo, and the "Complete Solutions For Epigenetics" slogan are trademarks of Epigentek Group Inc.